Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
British Journal of Clinical Pharmacology
|
April 20, 2000
Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
K D Wilner, S B Demattos, R J Anziano, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
Ziprasidone and the pharmacokinetics of a combined oral contraceptive
G J Muirhead, J Harness, P R Holt, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers
J J Miceli, R J Anziano, L Robarge, et al.
Progress in Cardiovascular Diseases
|
March 28, 2001
The QT interval
M M Bednar, E P Harrigan, R J Anziano, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium
G Apseloff, D Mullet, K D Wilner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 16, 2001
Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon
N J Clear, A Milton, M Humphrey, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
F Aweeka, D Jayesekara, M Horton, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function
G Everson, K C Lasseter, K E Anderson, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug development
P A Milligan, M J Brown, B Marchant, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
British Journal of Clinical Pharmacology
|
April 20, 2000
Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
K D Wilner, S B Demattos, R J Anziano, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
Ziprasidone and the pharmacokinetics of a combined oral contraceptive
G J Muirhead, J Harness, P R Holt, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers
J J Miceli, R J Anziano, L Robarge, et al.
Progress in Cardiovascular Diseases
|
March 28, 2001
The QT interval
M M Bednar, E P Harrigan, R J Anziano, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium
G Apseloff, D Mullet, K D Wilner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 16, 2001
Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon
N J Clear, A Milton, M Humphrey, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
F Aweeka, D Jayesekara, M Horton, et al.
British Journal of Clinical Pharmacology
|
April 20, 2000
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function
G Everson, K C Lasseter, K E Anderson, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug development
P A Milligan, M J Brown, B Marchant, et al.
Page
of 1